Cite
HARVARD Citation
Chelbi, S. et al. (2016). NLRC5, a promising new entry in tumor immunology. Journal for immunotherapy of cancer. 4 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chelbi, S. et al. (2016). NLRC5, a promising new entry in tumor immunology. Journal for immunotherapy of cancer. 4 (1), p. . [Online].